1. A conceptual framework to develop a patient-reported experience measure of the quality of mental health care: a qualitative study of the PREMIUM project in France. Issue 1 (1st January 2021) Authors: Fernandes, S; Fond, G; Zendjidjian, X; Michel, P; Lançon, C; Berna, F; Schurhoff, F; Aouizerate, B; Henry, C; Etain, B; Samalin, L; Leboyer, M; Misdrahi, D; Llorca, PM; Coldefy, M; Auquier, P; Baumstarck, K; Boyer, L Journal: Journal of market access & health policy Issue: Volume 9:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Accelerating patient access to oncology medicines with multiple indications in Europe. Issue 1 (1st January 2021) Authors: Lawlor, R.; Wilsdon, T.; Darquennes, E.; Hemelsoet, D.; Huismans, J.; Normand, R.; Roediger, A. Journal: Journal of market access & health policy Issue: Volume 9:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Allocating treatment resources for hepatitis C in the UK: a constrained optimization modelling approach. Issue 1 (1st January 2021) Authors: Han, Ru; Liang, Shuyao; François, Clément; Aballea, Samuel; Clay, Emilie; Toumi, Mondher Journal: Journal of market access & health policy Issue: Volume 9:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. An algorithm to generate correlated input-parameters to be used in probabilistic sensitivity analyses. Issue 1 (1st January 2021) Authors: Neine, Mohamed; Curran, Desmond Journal: Journal of market access & health policy Issue: Volume 9:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. An overview of health technology assessments of gene therapies with the focus on cost-effectiveness models. Issue 1 (1st January 2021) Authors: Pochopień, Michał; Paterak, Ewelina; Clay, Emilie; Janik, Justyna; Aballea, Samuel; Biernikiewicz, Małgorzata; Toumi, Mondher Journal: Journal of market access & health policy Issue: Volume 9:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. An updated cost-utility model for onasemnogene abeparvovec (Zolgensma®) in spinal muscular atrophy type 1 patients and comparison with evaluation by the Institute for Clinical and Effectiveness Review (ICER). Issue 1 (1st January 2021) Authors: Dean, Rebecca; Jensen, Ivar; Cyr, Phil; Miller, Beckley; Maru, Benit; Sproule, Douglas M.; Feltner, Douglas E.; Wiesner, Thomas; Malone, Daniel C.; Bischof, Matthias; Toro, Walter; Dabbous, Omar Journal: Journal of market access & health policy Issue: Volume 9:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Bright line or lottery? On significance and value in medical decision making. Issue 1 (1st January 2021) Authors: Mahlich, Jörg; Dheban, Srirangan Journal: Journal of market access & health policy Issue: Volume 9:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cost-Effectiveness Analysis of a Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder. Issue 1 (1st January 2021) Authors: Velez, Fulton F.; Malone, Daniel C. Journal: Journal of market access & health policy Issue: Volume 9:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Economic evaluation of adverse events of dabrafenib plus trametinib versus nivolumab in patients with advanced BRAF-mutant cutaneous melanoma for adjuvant therapy in Germany. Issue 1 (1st January 2021) Authors: Wahler, S; Müller, A; Koll, C; Seyed-Abbaszadeh, P; Von Der Schulenburg, JM Journal: Journal of market access & health policy Issue: Volume 9:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Economic evaluation of betibeglogene autotemcel (Beti-cel) gene addition therapy in transfusion-dependent β-thalassemia. Issue 1 (1st January 2021) Authors: Kansal, Anuraag R.; Reifsnider, Odette S.; Brand, Sarah B.; Hawkins, Neil; Coughlan, Anna; Li, Shujun; Cragin, Lael; Paramore, Clark; Dietz, Andrew C.; Caro, J. Jaime Journal: Journal of market access & health policy Issue: Volume 9:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗